Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.04T, Eli Lilly(LLY) trades at $1,103.27. The stock has a price-to-earnings ratio of 54.89 and currently yields dividends of 52.3%.
During the trading session on 2025-11-27, Eli Lilly(LLY) shares reached a daily high of $1,118.00 and a low of $1,098.10. At a current price of $1,103.27, the stock is +0.5% higher than the low and still -1.3% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 3.09M, versus its average volume of 3.99M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,118.00 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,118.00 and a low of $623.78.
LLY News
New insider activity at Eli Lilly & Co ( (LLY) ) has taken place on November 26, 2025. TipRanks Black Friday Sale Claim 60% off TipRanks Premium for the data-ba...
JPMorgan Chase (JPM) is pounding the table on the stock of Eli Lilly & Co. (LLY) after its market capitalization recently surpassed $1 trillion. TipRanks Black...
The stock recently reached beyond $1,000. Investors generally don't turn to pharmaceutical stocks with expectations of high growth in a short period of time. I...
Analyst ratings
73%
of 30 ratingsMore LLY News
Eli Lilly became the first healthcare company to reach a US$1 trillion market capitalization, propelled by unprecedented demand for its diabetes and weight loss...
Below is Validea's guru fundamental report for ELI LILLY AND CO (LLY). Of the 22 guru strategies we follow, LLY rates highest using our Twin Momentum Investor m...
Despite an already strong run, Eli Lilly and Company ( ) shares have been powering on, with a gain of 30% in the last thirty days. Looking back a bit further, i...
The rapidly expanding market for GLP-1 drugs has added massively to Eli Lilly's market cap. Just a handful of companies have entered the rarefied trillionaire...
Analysts at Wall Street firm Bernstein have raised their price target on Eli Lilly’s (LLY) stock to $1,300 from $1,100, and maintained a Buy rating on the share...
Morgan Stanley raised the firm’s price target on Eli Lilly (LLY) to $1,290 from $1,171 and keeps an Overweight rating on the shares. The firm refreshed its mode...
Dow Jones Futures, Bitcoin Rise; Nvidia, Apple, Eli Lilly In Focus 11/21/2025 The stock market needs to show a lot of strength after damaging recent losses. Wa...
